Eli Lilly: The Worst May Be Already Over (Earnings Preview)

Eli Lilly (LLY) is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Analysts expect continued volume-driven revenue and margin expansion, with consensus seeing EPS and sales growth well above industry averages through 2026. LLY's Q1 saw 45% revenue growth but a minor EPS miss due to IPR&D charges; management reaffirmed full-year guidance, and volume growth is expected to offset price erosion.